Clinical Trial Update: A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating solriamfetol for attention-deficit/hyperactivity disorder has completed, focusing on efficacy and safety. The snippet confir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Solriamfetol (solriamfetol)

Snippet

Sponsor: Axsome Therapeutics, Inc. | Conditions: ADHD | Phase 3 | Status: COMPLETED